WallStSmart
ACHV

Achieve Life Sciences Inc

NASDAQ: ACHV · HEALTHCARE · BIOTECHNOLOGY

$4.15
-2.81% today

Updated 2026-04-29

Market cap
$220.95M
P/E ratio
P/S ratio
5.09x
EPS (TTM)
$-1.25
Dividend yield
52W range
$2 – $6
Volume
1.1M

Achieve Life Sciences Inc (ACHV) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-19.68M$-23.34M$-12.31M$34.88M$-26.84M$-20.26M$-43.49M$-35.93M$-17.31M$-9.10M$-29.68M$-9.11M$-10.62M$-15.22M$-13.47M$-29.44M$-37.57M$-24.48M$-29.77M$-49.47M
Capital expenditures$789386.00$1.40M$3000.00$15000.00$68000.00$79000.00$291000.00$253000.00$82000.00$371000.00$46000.00$46000.00$46000.00$53000.00$17000.00$17000.00$0.00$21000.00$0.00$3000.00
Depreciation
Stock-based comp$2.17B$1.66B$174000.00$380000.00$642000.00$1.19M$2.17M$2.83M$3.86M$2.33M$1.65M$348000.00$854000.00$1.20M$1.29M$2.19M$3.27M$3.44M$5.33M$8.76M
Free cash flow$-20.47M$-24.73M$-12.31M$34.86M$-26.91M$-20.34M$-43.78M$-36.18M$-17.39M$-9.47M$-29.73M$-9.15M$-10.67M$-15.27M$-13.49M$-29.46M$-37.57M$-24.50M$-29.77M$-49.47M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$4.98M$-10.44M$-3.48M$13.30M$6.41M$-19.08M$5.54M$4.01M$7.14M$19.19M$-18.25M